Page 234 - PRECONGRESS COURSE 06
P. 234
ESTHER Trial
Demonstrated the role for AMH and Bodyweight
in managing the Hyper Responder safety.
OHSS and/or OHSS preventive interventions occurred less frequently (p<0.05).
ESTHER trial Algorythm
ng/ml
2.1 2.1-2.2 2.4
2.5 2.7-2.8 2.9-3.1 3.2-3.4 3.5-3.8 3.9-4.5 4.6-5.5 5.6
Average Daily Dosage in IU
Median AMH: 16 pMol/l Average Dose: 10 μg/day = 145 IU/day
174
176
167
158
148
139
130
121
111
102
93
234
Page 230 of 258
